
Releases
Nuvation Bio Sets Date for Second Quarter 2026 Financial Review
Nuvation Bio will detail its second quarter 2026 financial performance and provide a broader update on its oncology pipeline during a conference call scheduled for August 6, 2026, at 8:00 a.m. ET. The session aims to offer stakeholders a clear view of the company's current development milestones.
























